The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer: a cross sectional study

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Hyuna Sung, Jacques Ferlay, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2021 · 109.5K citations · Full text

Optimal caliper widths for propensity‐score matching when estimating differences in means and differences in proportions in observational studies

Peter C. Austin · Pharmaceutical Statistics · 2010 · 3.7K citations · Full text

Treatment Effect, Propensity-score Matching, Quasi-experiment +16

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

Thierry Conroy, Pascal Hammel, Mohamed Hebbar et al. · New England Journal of Medicine · 2018 · 2.7K citations · Full text

STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery

Ginimol Mathew, Riaz Agha, Joerg Albrecht et al. · International Journal of Surgery · 2021 · 2.1K citations · Full text

Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

John P. Neoptolemos, Daniel H. Palmer, Paula Ghaneh et al. · The Lancet · 2017 · 1.9K citations · Full text